Navigation Links
WuXi PharmaTech Announces Second-Quarter 2009 Results
Date:8/11/2009

t income- continuing operations 14,686 10,696 37% 26,421 25,865 2% GAAP net margin- continuing operations 22% 15% 21% 21% Adjustments: Share-based compensation 2,659 3,419 4,658 6,397 Amortization of acquired intangible assets 764 4,166 1,528 4,550 Deferred tax impact related to acquired intangible assets (296) (1,632) (592) (1,784) Non-GAAP net income 17,813 16,649 7% 32,015 35,028 (9%) Non-GAAP net margin 27% 24% 25% 28% GAAP net income 14,686 8,520 72% 26,421 22,381 18% Add back: Depreciation and amortization 5,620 10,672 10,627 15,526 Interest (income) expenses, net (144) 21 (94) (495) Income tax expenses 2,069 (3,097) 3,952 (1,972) EBITDA 22,231 16,116 38% 40,906 35,440 15% Adjustments Share-based compensation 2,659 3,419 4,658 6,397 Mark-to-market gains (losses) from foreign- currency forward contracts 401 2,515 (2,219) (168) Adjusted EBITDA 25,291 22,050 15% 43,345 41,669 4% Income attributable to holders of ADS (Non-GAAP): Basic 17,813 16,649 7% 32,015 35,028 (9%) Diluted 17,813 16,649 7% 32,015 35,028 (9%) Basic earnings per ADS (Non-GAAP) 0.26 0.27 (1%) 0.47 0.56 (16%) Diluted earnings per ADS (Non-GAAP) 0.24 0.23 7% 0.44 0.48 (9%)
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
2. WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
3. WuXi PharmaTech Receives Award from BASF
4. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
5. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
6. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
7. WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
8. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
9. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
10. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
11. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Mass (PRWEB) January 21, 2015 Cambridge Semantics, ... Web technology, today announced that 2014 was a record-breaking year ... the capabilities of the Anzo Smart Data Platform and our ... and utilize insights from diverse data which led to record ...
(Date:1/22/2015)... January 22, 2015 Pipette.com has added ... to their comprehensive portfolio of Eppendorf products. , The ... purchase a Centrifuge 5424/5424 R and receive the following:, ... Eppendorf Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... 22, 2015 Selexis SA, a serial ... Cell Banks (RCBs) used for drug discovery to commercial ... will include Next-Generation Sequencing (NGS) data packages. ... biologic manufacturing by ensuring the integrity of the gene, ...
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
Breaking Biology Technology:Cambridge Semantics Announces Record Results for 2014 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2
... , , , ... (GSK) (NYSE: GSK ) today announced that it has completed ... share capital of Stiefel for a cash consideration of $2.9 billion. ... of the agreement, GSK may be obligated to make additional cash payments ...
... ... SBIR grants from the National Institutes of Health to develop original in silico technologies to ... rates of DNA and RNA experiments. , ... (Vocus) July 22, 2009 -- DNA Software, Inc. has been awarded three Fast ...
... , , PHILADELPHIA and LONDON, ... and often cited compendium of pharmaceutical research and development statistics, the ... year,s Factbook offers extended content including patent information and ... "The R&D Factbook provides the data that ...
Cached Biology Technology:GlaxoSmithKline Completes Acquisition of Stiefel 2DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies 2DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies 3DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies 4Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook 2
(Date:12/19/2014)... Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced the addition ... Systems Market" report to their offering. ... security market is estimated to grow at a CAGR of ... a larger share in this market, Canada ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB SM ... (GCP) audit to confirm its adherence to current U.S. ... HITLAB to conduct regulated smart device and smart phone ... and research quality. "HITLAB is determined to ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... advances in technology, it is important to upgrade biometric ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... an Applera Corporation business, today announced the introduction ... Provider Program, a new program for service providers ... solution for gene expression analysis, including the highly ... and gold-standard TaqMan® Gene Expression Assays for target ...
... an organization dedicated to humane alternatives to the use of ... your own that requires using animals as part of the ... Physicians Committee for Responsible Medicine, you invent your own test. ... has developed the world's first cruelty-free insulin assay, a test ...
... today that they have entered into a non-exclusive ... customers with new software solutions for GeneChip(R) data ... develop a new software package for Affymetrix, ArrayAssist(R) ... statistical analysis solution of Affymetrix gene expression microarrays. ...
Cached Biology News:Harnessing microbes, one by one, to build a better nanoworld 2PCRM develops world's first cruelty-free insulin assay 2Affymetrix and Stratagene Announce Strategic Software Alliance 2
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (C7046) ... assistance. Mfr Desig: Corning ...
... Disposable. Virgin, optically clear polystyrene ... and alphanumeric coordinates for cell counting. ... number is a new product number, ... number. If showing no availability yet, ...
... ® Ek Adaptor encodes a T7 ... site (rbs), ATG translation initation codon, and ... is a small epitope tag (11 aa) ... target protein with T7•Tag Monoclonal Antibody and ...
Biology Products: